Cardiotrophin-1 administration prevents the renal toxicity of iodinated contrast media in rats

Toxicological Sciences

Volumn 132, Issue 2, 2013, Pages 493-501

  Quiros, Yaremi ^a   Sánchez gonzález, Penelope D ^a   López herńandez, Francisco J ^b,c,d   Morales, Ana I ^b,c   López novoa, José M ^b,c  

^a Bio inRen SL   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA IBSAL   (Spain)

^d Instituto de Estudios de Ciencias de La Salud de Castilla y Leon   (Spain)

Author keywords

Acute kidney injury; Cardiotrophin 1; Contrast nephrotoxicity; Contrast induced nephropathy; Nephroprotection.

Indexed keywords

CARDIOTROPHIN 1; CASPASE; CREATININE; DIATRIZOATE; GENTAMICIN; KIDNEY INJURY MOLECULE 1; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE SEVERITY; ENZYME ACTIVATION; EPITHELIZATION; HISTOPATHOLOGY; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY TUBULE; KIDNEY TUBULE DAMAGE; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; RENAL PROTECTION; TISSUE LEVEL; UREA BLOOD LEVEL; URINARY EXCRETION;

ANIMALS; CONTRAST MEDIA; CYTOKINES; KIDNEY; MALE; RATS; RATS, WISTAR;

EID: 84875271965     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kft007     Document Type: Article

References (52)

1. ACT Investigators. (2011). Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: Main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation. 124, 1250-1259.
2. Amini, M., Salarifar, M., Amirbaigloo, A., Masoudkabir, F., and Esfahani, F. (2009). N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: A randomized clinical trial. Trials 10, 45.
3. Asaga, T., Ueki, M., Chujo, K., and Taie, S. (2008). JTE-607, an inflammatory cytokine synthesis inhibitor, attenuates ischemia/reperfusion-induced renal injury by reducing neutrophil activation in rats. J. Biosci. Bioeng. 106, 22-26.
4. Best, P. J., Lennon, R., Ting, H. H., Bell, M. R., Rihal, C. S., Holmes, D. R., and Berger, P. B. (2002). The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J. Am. Coll. Cardiol. 39, 1113-1119.
5. Brar, B. K., Stephanou, A., Liao, Z., O'Leary, R. M., Pennica, D., Yellon, D. M., and Latchman, D. S. (2001). Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation. Cardiovasc. Res. 51, 265-274.
6. Brown, J. R., Block, C. A., Malenka, D. J., O'Connor, G. T., Schoolwerth, A. C., and Thompson, C. A. (2009). Sodium bicarbonate plus N-acetylcysteine prophylaxis: A meta-analysis. JACC. Cardiovasc. Interv. 2, 1116-1124.
7. Brown, J. R., Malenka, D. J., DeVries, J. T., Robb, J. F., Jayne, J. E., Friedman, B. J., Hettleman, B. D., Niles, N. W., Kaplan, A. V., Schoolwerth, A. C., et al. (2008). Transient and persistent renal dysfunction are predictors of survival after percutaneous coronary intervention: Insights from the Dartmouth Dynamic Registry. Catheter. Cardiovasc. Interv. 72, 347-354.
8. Bustos, M., Beraza, N., Lasarte, J. J., Baixeras, E., Alzuguren, P., Bordet, T., and Prieto, J. (2003). Protection against liver damage by cardiotrophin-1: A hepatocyte survival factor up-regulated in the regenerating liver in rats. Gastroenterology 125, 192-201.
9. Calvin, A. D., Misra, S., and Pflueger, A. (2010). Contrast-induced acute kidney injury and diabetic nephropathy. Nat. Rev. Nephrol. 6, 679-688.
10. Chertow, G. M., Burdick, E., Honour, M., Bonventre, J. V., and Bates, D. W. (2005). Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J. Am. Soc. Nephrol. 16, 3365-3370.
11. Dolcet, X., Soler, R. M., Gould, T. W., Egea, J., Oppenheim, R. W., and Comella, J. X. (2001). Cytokines promote motoneuron survival through the Janus kinase-dependent activation of the phosphatidylinositol 3-kinase pathway. Mol. Cell. Neurosci. 18, 619-631.
12. Ferreira, L., Quiros, Y., Sancho-Martínez, S. M., García-Sánchez, O., Raposo, C., López-Novoa, J. M., González-Buitrago, J. M., and López-Hernández, F. J. (2011). Urinary levels of regenerating islet-derived protein III β and gelsolin differentiate gentamicin from cisplatin-induced acute kidney injury in rats. Kidney Int. 79, 518-528.
13. Garcia-Criado, F. J., Eleno, N., Santos-Benito, F., Valdunciel, J. J., Reverte, M., Lozano-Sánchez, F. S., Ludeña, M. D., Gomez-Alonso, A., and López-Novoa, J. M. (1998). Protective effect of exogenous nitric oxide on the renal function and inflammatory response in a model of ischemia-reperfusion. Transplantation 66, 982-990.
14. Ghosh, S., Ng, L. L., Talwar, S., Squire, I. B., and Galiñanes, M. (2000). Cardiotrophin-1 protects the human myocardium from ischemic injury. Comparison with the first and second window of protection by ischemic preconditioning. Cardiovasc. Res. 48, 440-447.
15. Gupta, R., Gurm, H. S., Bhatt, D. L., Chew, D. P., and Ellis, S. G. (2005). Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter. Cardiovasc. Interv. 64, 442-448.
16. Harjai, K., Shenoy, C., Raizada, A., Eswaran, M., Acharji, S., Sattur, S., Orshaw, P., and Devarakonda, S. (2008). Major adverse noncardiac events after PCI as predictors of long-term mortality. J. Interv. Cardiol. 21, 395-402.
17. Heyman, S. N., Rosen, S., Khamaisi, M., Idée, J. M., and Rosenberger, C. (2010). Reactive oxygen species and the pathogenesis of radiocontrastinduced nephropathy. Invest. Radiol. 45, 188-195.
18. Ho, D. W., Yang, Z. F., Lau, C. K., Tam, K. H., To, J. Y., Poon, R. T., and Fan, S. T. (2006). Therapeutic potential of cardiotrophin 1 in fulminant hepatic failure: Dual roles in antiapoptosis and cell repair. Arch. Surg. 141, 1077-84.
19. Hsu, D. Z., Li, Y. H., Chu, P. Y., Periasamy, S., and Liu, M. Y. (2011). Sesame oil prevents acute kidney injury induced by the synergistic action of aminoglycoside and iodinated contrast in rats. Antimicrob. Agents Chemother. 55, 2532-2536.
20. Iniguez, M., Berasain, C., Martinez-Ansó, E., Bustos, M., Fortes, P., Pennica, D., Avila, M. A., and Prieto, J. (2006). Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning. J. Exp. Med. 203, 2809-2815.
21. Jin, H., Yang, R., Keller, G. A., Ryan, A., Ko, A., Finkle, D., Swanson, T. A., Li, W., Pennica, D., Wood, W. I., et al. (1996). In vivo effects of cardiotrophin-1. Cytokine 8, 920-926.
22. Kunisada, K., Negoro, S., Tone, E., Funamoto, M., Osugi, T., Yamada, S., Okabe, M., Kishimoto, T., and Yamauchi-Takihara, K. (2000). Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc. Natl. Acad. Sci. U.S.A. 97, 315-319.
23. Laville, M., and Juillard, L. (2010). Contrast-induced acute kidney injury: How should at-risk patients be identified and managed? J. Nephrol. 23, 387-398.
24. Lopez, N., Díez, J., and Fortuño, M. A. (2005). Characterization of the protective effects of cardiotrophin-1 against non-ischemic death stimuli in adult cardiomyocytes. Cytokine 30, 282-292.
25. Maioli, M., Toso, A., Leoncini, M., Gallopin, M., Musilli, N., and Bellandi, F. (2012). Persistent renal damage after contrast-induced acute kidney injury: Incidence, evolution, risk factors, and prognosis. Circulation 125, 3099-3107.
26. Marques, J. M., Belza, I., Holtmann, B., Pennica, D., Prieto, J., and Bustos, M. (2007). Cardiotrophin-1 is an essential factor in the natural defense of the liver against apoptosis. Hepatology 45, 639-648.
27. McCullough, P. A., Stacul, F., Becker, C. R., Adam, A., Lameire, N., Tumlin, J. A., and Davidson, C. J. (2006). Contrast-Induced Nephropathy (CIN) consensus working panel: Executive summary. Rev. Cardiovasc. Med. 7, 177-197.
28. Mehran, R., Aymong, E. D., Nikolsky, E., Lasic, Z., Iakovou, I., Fahy, M., Mintz, G. S., Lansky, A. J., Moses, J. W., Stone, G. W., et al. (2004). A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J. Am. Coll. Cardiol. 44, 1393-1399.
29. Middleton, G., Hamanoue, M., Enokido, Y., Wyatt, S., Pennica, D., Jaffray, E., Hay, R. T., and Davies, A. M. (2000). Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons. J. Cell Biol. 148, 325-332.
30. Morales, A. I., Buitrago, J. M., Santiago, J. M., Fernández-Tagarro, M., López-Novoa, J. M., and Pérez-Barriocanal, F. (2002). Protective effect of transresveratrol on gentamicin-induced nephrotoxicity. Antioxid. Redox Signal. 4, 893-898.
31. Morales, A. I., Detaille, D., Prieto, M., Puente, A., Briones, E., Arévalo, M., Leverve, X., López-Novoa, J. M., and El-Mir, M. Y. (2010). Metformin prevents experimental gentamicin-induced nephropathy by a mitochondriadependent pathway. Kidney Int. 77, 861-869.
32. Morales, A. I., Vicente-Sánchez, C., Sandoval, J. M., Egido, J., Mayoral, P., Arévalo, M. A., Fernández-Tagarro, M., López-Novoa, J. M., and Pérez-Barriocanal, F. (2006). Protective effect of quercetin on experimental chronic cadmium nephrotoxicity in rats is based on its antioxidant properties. Food Chem. Toxicol. 44, 2092-2100.
33. Nash, K., Hafeez, A., and Hou, S. (2002). Hospital-acquired renal insufficiency. Am. J. Kidney Dis. 39, 930-936.
34. Nomura, N., Asano, M., Saito, T., Sasaki, S., Suzuki, H., Manabe, T., and Mishima, A. (2003). Cardiotrophin-1 is a prophylactic against the development of chronic hypoxic pulmonary hypertension in rats. Ann. Thorac. Surg. 76, 237-243.
35. Oppenheim, R. W., Wiese, S., Prevette, D., Armanini, M., Wang, S., Houenou, L. J., Holtmann, B., Gotz, R., Pennica, D., and Sendtner, M. (2001). Cardiotrophin-1, a muscle-derived cytokine, is required for the survival of subpopulations of developing motoneurons. J. Neurosci. 21, 1283-1291.
36. Pasternak, J. J., and Williamson, E. E. (2012). Clinical pharmacology, uses, and adverse reactions of iodinated contrast agents: A primer for the nonradiologist. Mayo Clin. Proc. 87, 390-402.
37. Peng, H., Sola, A., Moore, J., and Wen, T. (2010). Caspase inhibition by cardiotrophin-1 prevents neuronal death in vivo and in vitro. J. Neurosci. Res. 88, 1041-1051.
38. Pennica, D., Wood, W. I., and Chien, K. R. (1996). Cardiotrophin-1: A multifunctional cytokine that signals via LIF receptor-gp 130 dependent pathways. Cytokine Growth Factor Rev. 7, 81-91.
39. Quiros, Y., Ferreira, L., Sancho-Martínez, S. M., González-Buitrago, J. M., López-Novoa, J. M., and López-Hernández, F. J. (2010). Sub-nephrotoxic doses of gentamicin predispose animals to developing acute kidney injury and to excrete ganglioside M2 activator protein. Kidney Int. 78, 1006-1015.
40. Rihal, C. S., Textor, S. C., Grill, D. E., Berger, P. B., Ting, H. H., Best, P. J., Singh, M., Bell, M. R., Barsness, G. W., Mathew, V., et al. (2002). Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105, 2259-2264.
41. Rodriguez-Pena, A., Garcia-Criado, F. J., Eleno, N., Arevalo, M., and Lopez-Novoa, J. M. (2004). Intrarenal administration of molsidomine, a molecule releasing nitric oxide, reduces renal ischemia-reperfusion injury in rats. Am. J. Transplant. 4, 1605-1613.
42. Ruixing, Y., Jinzhen, W., Dezhai, Y., and Jiaquan, L. (2007). Cardioprotective role of cardiotrophin-1 gene transfer in a murine model of myocardial infarction. Growth Factors 25, 286-294.
43. Ruiz-Hurtado, G., Gómez-Hurtado, N., Fernández-Velasco, M., Calderón, E., Smani, T., Ordoñez, A., Cachofeiro, V., Boscá, L., Díez, J., Gómez, A. M., et al. (2012). Cardiotrophin-1 induces sarcoplasmic reticulum Ca(2+) leak and arrhythmogenesis in adult rat ventricular myocytes. Cardiovasc. Res. 96, 81-89.
44. Sanchez-Gonzalez, P. D., Lopez-Hernandez, F. J., Perez-Barriocanal, F., Morales, A. I., and Lopez-Novoa, J. M. (2011). Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumour activity. Nephrol. Dial. Transplant. 26, 3484-3495.
45. Sendeski, M. M. (2011). Pathophysiology of renal tissue damage by iodinated contrast media. Clin. Exp. Pharmacol. Physiol. 38, 292-299.
46. Sinning, J. M., Ghanem, A., Steinhäuser, H., Adenauer, V., Hammerstingl, C., Nickenig, G., and Werner, N. (2010). Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC. Cardiovasc. Interv. 3, 1141-1149.
47. Solomon, R., and Dauerman, H. L. (2010). Contrast-induced acute kidney injury. Circulation 122, 2451-2455.
48. Trivedi, H., Daram, S., Szabo, A., Bartorelli, A. L., and Marenzi, G. (2009). High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy. Am. J. Med. 122, 874.e9-874.15.
49. Trivedi, H., Nadella, R., and Szabo, A. (2010). Hydration with sodium bicarbonate for the prevention of contrast-induced nephropathy: A meta-analysis of randomized controlled trials. Clin. Nephrol. 74, 288-296.
50. Tumlin, J., Stacul, F., Adam, A., Becker, C. R., Davidson, C., Lameire, N., and McCullough, P. A. (2006). Pathophysiology of contrast-induced nephropathy. Am. J. Cardiol. 98(6A), 14K-20K.
51. Yang, Z. F., Lau, C. K., Ngai, P., Lam, S. P., Ho, D. W., Poon, R. T., and Fan, S. T. (2008). Cardiotrophin-1 enhances regeneration of cirrhotic liver remnant after hepatectomy through promotion of angiogenesis and cell proliferation. Liver Int. 28, 622-631.
52. Zhang, T., Shen, L. H., Hu, L. H., and He, B. (2011). Statins for the prevention of contrast-induced nephropathy: A systematic review and meta-analysis. Am. J. Nephrol. 33, 344-351.